Skip to main content
. 2010 Apr 9;37(5):1966–1975. doi: 10.1118/1.3319498

Figure 3.

Figure 3

Dose distributions of individual phase (phase 3 for lung case) plan showed the target (red colorwash) dose coverage and conformity between the SHIFT (A1, A2), DAD (B1, B2), and IPO (C1, C2) schemes for the lung case.